STATE STREET CORP - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,854,164
+42.5%
2,335,110
+4.7%
0.00%
Q2 2023$6,915,285
+133.6%
2,230,737
+4.7%
0.00%
Q1 2023$2,960,657
-64.5%
2,129,969
-49.1%
0.00%
Q4 2022$8,335,398
+93.5%
4,188,642
+96.5%
0.00%
Q3 2022$4,307,000
-48.1%
2,132,139
-18.3%
0.00%
Q2 2022$8,295,000
-18.7%
2,608,362
+6.6%
0.00%
-100.0%
Q1 2022$10,202,000
-14.3%
2,446,545
-1.6%
0.00%0.0%
Q4 2021$11,910,000
-11.8%
2,486,353
-1.7%
0.00%0.0%
Q3 2021$13,509,000
-3.7%
2,529,797
-7.6%
0.00%0.0%
Q2 2021$14,023,000
-14.4%
2,738,815
+12.5%
0.00%0.0%
Q1 2021$16,388,000
+36.1%
2,435,002
-7.6%
0.00%0.0%
Q4 2020$12,043,000
+24.5%
2,635,270
+5.7%
0.00%0.0%
Q3 2020$9,673,000
-26.8%
2,493,033
-10.2%
0.00%0.0%
Q2 2020$13,213,000
+57.1%
2,775,931
+14.8%
0.00%0.0%
Q1 2020$8,412,000
-23.1%
2,417,142
+6.5%
0.00%0.0%
Q4 2019$10,944,000
+104.4%
2,270,522
+23.0%
0.00%
Q3 2019$5,355,000
-64.9%
1,846,439
-13.3%
0.00%
-100.0%
Q2 2019$15,278,000
-44.4%
2,130,847
+9.8%
0.00%
-50.0%
Q1 2019$27,497,000
-0.3%
1,940,492
-4.8%
0.00%
-33.3%
Q4 2018$27,593,000
-39.8%
2,039,393
-1.2%
0.00%
-25.0%
Q3 2018$45,819,000
+48.7%
2,064,710
+9.9%
0.00%
+33.3%
Q2 2018$30,815,0001,877,9730.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$90,819,89014.58%
Eversept Partners, LP 2,644,988$11,161,8490.94%
TPG GP A, LLC 12,328,767$52,027,3970.90%
Nantahala Capital Management 2,212,757$9,337,8350.80%
Rubric Capital Management LP 4,024,500$16,983,3900.64%
Hedges Asset Management LLC 84,600$357,0120.31%
Signature Wealth Management Partners, LLC 66,666$281,3310.28%
Tejara Capital Ltd 96,672$407,9560.23%
Tranquilli Financial Advisor LLC 71,414$301,3670.22%
EAM Investors, LLC 230,271$971,7440.19%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders